00000000cam 2200000zi 4500
0019.965468
003CaOODSP
00520260826142046
006m     o  d f      
007cr cn|||||||||
008260826e20260826onc     ob   f000 0 eng d
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aH113-30/2026-2E-PDF
24500|aHalohydantoins and associated end-use products.
264 1|aOttawa, Ontario : |bHealth Canada = Santé Canada, |c26 August 2026.
264 4|c©2026
300 |a1 online resource (22 pages).
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
4901 |aProposed special review decision, |x2561-6366 ; |vPSRD2026-02
500 |aIssued also in French under title: Halohydantoïnes et préparations commerciales connexes.
500 |a"This document is published by the Health Canada Healthy Environments and Consumer Safety Branch."
504 |aIncludes bibliographical references.
650 0|aDisinfection and disinfectants|xCertification|zCanada.
650 0|aDisinfection and disinfectants|xRisk assessment|zCanada.
650 0|aDisinfection and disinfectants|xHealth aspects.
650 0|aDisinfection and disinfectants|xToxicology.
650 0|aPesticides|xRisk mitigation|zCanada.
7101 |aCanada. |bHealthy Environments and Consumer Safety Branch, |eissuing body.
77508|tHalohydantoïnes et préparations commerciales connexes.|w(CaOODSP)9.965469
830#0|aProposed special review decision,|x2561-6366 ; |vPSRD2026-02.|w(CaOODSP)9.853990
85640|qPDF|s522 KB|uhttps://publications.gc.ca/collections/collection_2026/sc-hc/h113-30/H113-30-2026-2-eng.pdf